Lonza Group AG (LZAGF.PK)
Swiss pharmaceutical supplier Lonza Group AG on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP for $5.5 billion in cash to broaden its product range.
Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.
* Says strong momentum in q3 gives us confidence to specify that core ebit is on track to cross 15% growth line for full-year 2016
* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing
ZURICH Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.
* Lonza to spend up to $300 million on health-supplements target